Azacitidine (Sandoz Inc)
Welcome to the PulseAid listing for the Azacitidine drug offered from Sandoz Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | azacitidine |
| SUBSTANCE NAME: | AZACITIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2013-09-16 |
| END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Azacitidine from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2013-09-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-3253_c62745c5-18d0-4638-b7e0-0b3fd8eec0a0 |
| PRODUCT NDC: | 0781-3253 |
| APPLICATION NUMBER: | NDA050794 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers:
